Gain Fat—Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis
Cancer cell plasticity facilitates the development of therapy resistance and malignant progression. De-differentiation processes, such as an epithelial-mesenchymal transition (EMT), are known to enhance cellular plasticity. Here, we demonstrate that cancer cell plasticity can be exploited therapeuti...
Saved in:
Published in | Cancer cell Vol. 35; no. 1; pp. 17 - 32.e6 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
14.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cancer cell plasticity facilitates the development of therapy resistance and malignant progression. De-differentiation processes, such as an epithelial-mesenchymal transition (EMT), are known to enhance cellular plasticity. Here, we demonstrate that cancer cell plasticity can be exploited therapeutically by forcing the trans-differentiation of EMT-derived breast cancer cells into post-mitotic and functional adipocytes. Delineation of the molecular pathways underlying such trans-differentiation has motivated a combination therapy with MEK inhibitors and the anti-diabetic drug Rosiglitazone in various mouse models of murine and human breast cancer in vivo. This combination therapy provokes the conversion of invasive and disseminating cancer cells into post-mitotic adipocytes leading to the repression of primary tumor invasion and metastasis formation.
[Display omitted]
•EMT-derived breast cancer cells can differentiate into post-mitotic adipocytes•Adipogenesis disconnects cancer cells from an invasive and oncogenic phenotype•EMT/MET transcription factors and TGF-β signaling regulate cancer adipogenesis•Adipogenesis-inducing drug combinations repress metastasis in preclinical models
Ronen et al. show that the cellular plasticity of cancer cells undergoing EMT can be exploited to force trans-differentiation of breast cancer cells into post-mitotic and functional adipocytes, leading to the repression of primary tumor invasion and metastasis formation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1535-6108 1878-3686 |
DOI: | 10.1016/j.ccell.2018.12.002 |